Antibiotics Awareness Week is November 12-18.
We can’t become desensitized to the cause.
As a healthcare professional, you know antibiotics are not always the solution. In fact, you know they contribute to one of the largest and most urgent health problems in the world. Antibiotics Awareness Week is a great time to educate the world about the importance of Antimicrobial Stewardship.
Discover the Test Target Treat™ initiative
Today, more than half of all hospital patients receive an antibiotic. And 30-50% of antibiotic use in hospitals is unnecessary or inappropriate.2 In Europe, approximately 80% to 90% of antibiotic prescriptions are written by general practitioners.2 One of the most promising solutions to antibiotic resistance is to have the healthcare industry fundamentally change the way it prescribes and uses antibiotics.
When someone takes an antibiotic that they do not need, they are needlessly exposed to the side effects of the drug and do not get any benefit from it.3
The Test Target Treat™ initiative was created to help you make targeted treatment decisions sooner — reducing inappropriate antimicrobial use and the spread of resistance.
Through educational resources, advice from leading infectious disease experts, and world-class diagnostic tools, we hope to create a shift in treatment trends, moving away from the broad over-prescription of antibiotics, which spawned the growing prevalence of serious healthcare-associated infections like MRSA, towards more targeted therapy.
Best-in-class rapid diagnostics for better decisions around antibiotics
In this uncertain age of antibiotic resistance, it’s never been more important to know for sure which pathogen you’re treating. Using rapid diagnostics to distinguish between viral and bacterial infections makes it significantly easier to decide whether or not to prescribe antibiotics. Abbott offers best-in-class rapid diagnostic tests that help you quickly and accurately identify the source of the infection, define the most appropriate treatment strategy — and get the best possible result. Learn more about our rapid diagnostics which can reduce diagnostic uncertainty and help guide antibiotic decision-making during a patient’s visit.
Accurately read and interpret lateral flow tests in just seconds.
BinaxNOW® rapid in vitro diagnostic tests identify a variety of infectious diseases at the point of care. Our technologies detect bacteria and viruses causing upper and lower respiratory tract infections, including Legionnaires' disease, pneumonia, RSV and influenza, as well as pathogens causing filariasis and malaria.
Ways to prevent and control the spread of antibiotic resistance
Prevent infections by ensuring your hands, instruments, and environments are clean.
Only prescribe and dispense antibiotics when they are needed, according to current guidelines.
Report antibiotic-resistant infections to surveillance teams.
Talk to your patients about how to take antibiotics correctly, antibiotic resistance and the dangers of misuse.
Talk to your patients about preventing infections (for example, vaccination, hand washing, safer sex, and covering nose and mouth when sneezing).